RespireRx Pharmaceuticals, Inc. engages in the discovery, development and commercialization of innovative pharmaceuticals for the treatment of neurological and psychiatric disorders. The company was founded by Carl W. Cotman, Wayne Pambianchi and Gary S. Lynch on February 10, 1987 and is headquartered in Glen Rock, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of RespireRx Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. RespireRx Pharmaceuticals Inc market cap is $365,400.00.
What is the 52-week high for RespireRx Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. RespireRx Pharmaceuticals Inc 52 week high is $0.0027 as of September 28, 2025.
What is the 52-week low for RespireRx Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. RespireRx Pharmaceuticals Inc 52 week low is $0.0001 as of September 28, 2025.
What is RespireRx Pharmaceuticals Inc stock price today?
RespireRx Pharmaceuticals Inc stock price today is $0.001.
What was RespireRx Pharmaceuticals Inc stock price yesterday?
RespireRx Pharmaceuticals Inc stock price yesterday was $0.0015.
What is the 50-day moving average of RespireRx Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. RespireRx Pharmaceuticals Inc 50-day moving average is $0.0011.